(Q47406465)

15 January 2018

http://europepmc.org/abstract/MED/29133952

title

Engaging homeostatic plasticity to treat depression (English)

1 reference

15 January 2018

http://europepmc.org/abstract/MED/29133952

author

Farr Niere

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29133952%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kimberly F Raab-Graham

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29133952%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

E R Workman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29133952%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

14 November 2017

1 reference

15 January 2018

http://europepmc.org/abstract/MED/29133952

published in

Molecular Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29133952%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29133952%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29133952%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

26-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29133952%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/mp.2017.225

9 June 2020

exact match

0 references

cites work

Glutamatergic modulators: the future of treating mood disorders?

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

The economic burden of adults with major depressive disorder in the United States (2005 and 2010).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

The GABAergic deficit hypothesis of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Rapid bidirectional switching of synaptic NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Animal models of neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Linking molecules to mood: new insight into the biology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

The molecular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Ketamine as a novel antidepressant: from synapse to behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Is there anything really novel on the antidepressant horizon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

A neurotrophic model for stress-related mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Mechanisms underlying the antidepressant response and treatment resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Neurocircuitry of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Ketamine Treatment and Global Brain Connectivity in Major Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Altered hippocampal morphology in unmedicated patients with major depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Medial prefrontal-hippocampal connectivity and motor memory consolidation in depression and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Repeated stress alters dendritic spine morphology in the rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

An excitatory synapse hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

A conserved BDNF, glutamate- and GABA-enriched gene module related to human depression identified by coexpression meta-analysis and DNA variant genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Rapid antidepressants stimulate the decoupling of GABA(B) receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3η

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Tissue plasminogen activator and plasminogen mediate stress-induced decline of neuronal and cognitive functions in the mouse hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Cellular changes in the postmortem hippocampus in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Stress impairs GABAergic network function in the hippocampus by activating nongenomic glucocorticoid receptors and affecting the integrity of the parvalbumin-expressing neuronal network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Causal relationship between stressful life events and the onset of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Fragile X protein FMRP is required for homeostatic plasticity and regulation of synaptic strength by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Synaptic dysfunction in depression: potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Deep brain stimulation for treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Homeostatic synaptic plasticity: local and global mechanisms for stabilizing neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Hebb and homeostasis in neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

NMDA receptor subunits: function and pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Synaptic plasticity of NMDA receptors: mechanisms and functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Metaplasticity at single glutamatergic synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Targeting glutamate signalling in depression: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Ketamine enantiomers in the rapid and sustained antidepressant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Effects of a ketamine metabolite on synaptic NMDAR function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

New targets for rapid antidepressant action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Acute suppression of spontaneous neurotransmission drives synaptic potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Signaling pathways underlying the rapid antidepressant actions of ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Mice lacking NMDA receptors in parvalbumin neurons display normal depression-related behavior and response to antidepressant action of NMDAR antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Tonic NMDA receptor-mediated current in prefrontal cortical pyramidal cells and fast-spiking interneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

An isolated pool of vesicles recycles at rest and drives spontaneous neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

mTOR signaling: at the crossroads of plasticity, memory and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Differential regulation of GluA1 expression by ketamine and memantine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Elongation factor-2 phosphorylation in dendrites and the regulation of dendritic mRNA translation in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

GABAB receptor coupling to G-proteins and ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

GABAB receptors modulate NMDA receptor calcium signals in dendritic spines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Contribution of Ih and GABAB to synaptically induced afterhyperpolarizations in CA1: a brake on the NMDA response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Common molecular pathways mediate long-term potentiation of synaptic excitation and slow synaptic inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

BDNF release is required for the behavioral actions of ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Dendritic protein synthesis, synaptic plasticity, and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Homeostatic regulation of AMPA receptor expression at single hippocampal synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Adaptation to synaptic inactivity in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Local presynaptic activity gates homeostatic changes in presynaptic function driven by dendritic BDNF synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Rapid synaptic scaling induced by changes in postsynaptic firing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Development of rat CA1 neurones in acute versus organotypic slices: role of experience in synaptic morphology and activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Neuronal density determines network connectivity and spontaneous activity in cultured hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Ketamine, sleep, and depression: current status and new questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

21 January 2018

Local sleep and learning

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Increased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Long-term course of brain-derived neurotrophic factor serum levels in a patient treated with deep brain stimulation of the lateral habenula.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

GABAB receptors and depression. Current status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Chronic antidepressants and GABA "B" receptors: a GABA hypothesis of antidepressant drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Acute systemic rapamycin induces neurobehavioral alterations in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

Activity-Dependent Arc Expression and Homeostatic Synaptic Plasticity Are Altered in Neurons from a Mouse Model of Angelman Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

FMRP regulates an ethanol-dependent shift in GABABR function and expression with rapid antidepressant properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.225

7 January 2021

inferred from DOI database lookup

Neuroplasticity in mood disorders

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29133952

12 December 2020

inferred from PubMed ID database lookup

Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29133952

12 December 2020

inferred from PubMed ID database lookup

Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29133952

12 December 2020